Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characteristics of PUFAs Composition in Preterm Infants and Its Impact on Disease Prognosis

NCT06045130 is registered in ClinicalTrials.gov with The First Hospital of Jilin University as lead sponsor.

NCT NCT06045130
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06045130 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characteristics of PUFAs Composition in Preterm Infants and Its Impact on Disease Prognosis
Lead sponsor
The First Hospital of Jilin University
Phase
Observational
Overall status
Not yet recruiting
Start date
September 21, 2023
Completion date
August 31, 2026
Enrollment
600 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

bpd - bronchopulmonary dysplasia, intraventricular hemorrhage, necrotizing enterocolitis, patent ductus arteriosus, periventricular leukomalacia, sepsis